Generic-Drug Maker Takes Novartis Battle To Full Fed. Circ.
A Chinese generic-drug maker wants the full Federal Circuit to take a look at a splintered appeals court ruling that allowed Novartis to maintain its monopoly on a multibillion-dollar multiple sclerosis...To view the full article, register now.
Already a subscriber? Click here to view full article